ALLIANCEBERNSTEIN L.P. - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 105 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$394,618
-16.1%
119,220
+2.4%
0.00%
Q1 2024$470,337
+27.7%
116,420
-3.6%
0.00%
Q4 2023$368,227
-1.5%
120,730
-3.1%
0.00%
Q3 2023$373,860
-19.8%
124,6200.0%0.00%
Q2 2023$466,079
+55.5%
124,620
+39.2%
0.00%
Q1 2023$299,825
-26.9%
89,500
+4.9%
0.00%
Q4 2022$410,293
-10.0%
85,300
+6.5%
0.00%
Q3 2022$456,000
-19.9%
80,1000.0%0.00%
Q2 2022$569,000
-1.6%
80,1000.0%0.00%
Q1 2022$578,000
-19.0%
80,100
+0.3%
0.00%
Q4 2021$714,000
-78.9%
79,900
-17.0%
0.00%
-100.0%
Q3 2021$3,376,000
+75.0%
96,288
+7.2%
0.00%0.0%
Q2 2021$1,929,000
+66.1%
89,800
+377.6%
0.00%0.0%
Q1 2021$1,161,000
+118.6%
18,802
+48.0%
0.00%
Q4 2020$531,00012,7000.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$14,143,0001.69%
CM Management, LLC 250,000$1,423,0001.59%
Ally Bridge Group (NY) LLC 360,000$2,048,0001.35%
EcoR1 Capital, LLC 6,184,861$35,192,0001.04%
Cormorant Asset Management, LP 1,547,181$8,803,0000.62%
K2 PRINCIPAL FUND, L.P. 605,419$3,445,0000.40%
FEDERATED HERMES, INC. 3,626,818$20,637,0000.06%
PDT Partners, LLC 68,754$391,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 355,612$2,023,0000.05%
Virtus ETF Advisers LLC 15,660$89,0000.04%
View complete list of ATEA PHARMACEUTICALS INC shareholders